Overview
The Global Dengue Vaccine Market is growing at a CAGR of 10.4% during the forecast period (2024-2031)
Dengue, also known as breakbone fever or "dandy fever," is primarily transmitted from person to person through the bite of an infected Aedes aegypti mosquito. Common symptoms of dengue include headache, high fever, fatigue, muscle pain, diarrhea, anemia, vomiting, and skin rashes.
Dengue vaccines are designed to prevent dengue fever in humans. Several vaccines are currently in clinical trials, showing promising results, such as TVD, TV003, TV005, TVDV, and TV.
Request for free sample:https://www.datamintelligence.com/download-sample/dengue-vaccine-market
Market Growth Trends
Increasing Collaborations by the Research Institutes for the Clinical Trials of the Dengue Vaccine is Expected to Drive Market Growth.
In response to the rising number of dengue cases across the country, the Indian Council of Medical Research (ICMR) has initiated a program to advance the development of a dengue vaccine.
Vaccine developers and pharmaceutical companies with a tetravalent dengue vaccine candidate that has completed Phase I and II clinical trials are invited to collaborate with ICMR to conduct Phase III trials and further develop the vaccine.
Get your customized report @https://www.datamintelligence.com/customize/dengue-vaccine-market
Market is segmented
By Product Type: CYD-TDV
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa
Market Key Players
· Sanofi
· Panacea Biotec
· Biological E. Limited
· GlaxoSmithKline plc
· Merck & Co.
· Takeda Pharmaceutical Company Ltd
· Vabiotec
· Medigen Biologics
Related Reports
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Contact Person: Sai. K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across
